2009-2013年浙江省11家医院肺癌患者康莱特注射液利用调查

Utilization of Kanglaite Injections in Lung Cancer Patients in 11 Hospitals of Zhejiang from 2009 to 2013

目的：评价浙江省11家医院肺癌患者使用抗肿瘤中药康莱特注射液的应用状况,对其用药数据进行分析。方法：抽取浙江省11家医院2009-2013年肺癌患者每年40 d康莱特注射液的用药医嘱,统计使用康莱特注射液用药金额、用药频度（DDDs）、科室分布以及医保使用类别等利用情况。结果：11家医院肺癌患者的康莱特注射液使用金额呈逐年上升趋势,其中2011年和2012年增长较快,2012年是2009年的1.77倍;康莱特注射液使用金额占药品消耗总金额的比例先降后升;五年间,11家医院康莱特注射液使用金额排名前三位的科室为肿瘤科、放疗科、胸外科;康莱特注射液的用药量和DDDs,也呈逐年递增的趋势,以2011年和2012年增速较快。结论：浙江省11家医院肺癌患者使用康莱特注射液呈现持续快速增长势头,其在临床的合理化应用有待进一步加强。

Objective： To evaluate the utilization of Kanglaite injections in lung cancer patients in 11 hospitals of Zhejiang and analyze the prescription data. Methods： Totally 40-day prescription data of the patients with lung cancer in 11 hospitals of Zhejiang were withdrawn every year from 2009 to 2013. The data in respect of the consumption sum,DDDs,department distribution and medical insurance category of Kanglaite injections were analyzed. Results： The consumption sum of Kanglaite injections used in the patients with lung cancer in 11 hospitals of Zhejiang showed an upward trend year by year,the growth in2011 and 2012 was the fastest,and the sum in 2012 was 1. 77-fold of that in 2009. The consumption sum proportion of Kanglaite injections in total amount of drug consumption rose after the first drop. The top 3 departments were oncology,radiotherapy and thoracic surgery in the five years. The dosage and DDDs of Kanglaite injections were also in an increase trend year by year,and the growth in 2011 and 2012 was the fastest. Conclusion： The utilization of Kanglaite injections in the patients with lung cancer in Zhejiang area shows a continuous rapid growth momentum,therefore,it is still essential to strengthen the reasonable application in clinics.